Stocks

J&J’s One-Shot Covid Vaccine Recommended for Emergency Use By Investing.com

© Reuters

By Yasin Ebrahim

Investing.com – An advisory panel to the Food and Drug Administration on Friday recommended approval of emergency authorization for Johnson & Johnson’s single-dose Covid-19 vaccine, paving the way for a third vaccine to enter the fray and help lead the fight against the pandemic.  

Johnson & Johnson (NYSE:) rose 1.6% in aftermarket hours

The FDA could grant that emergency use authorization over the weekend. It comes just days after the agency said the vaccine was 66.1% effective in preventing moderate-to-severe Covid-19 cases after 28 days. 

The efficacy of the drug differed across geographies amid new variants. It was 72% effective in the U.S., 66% in Latin America and 57% in South Africa. While the vaccine was less effective at preventing illness in South Africa, it was still highly effective at preventing severe disease. The pharmaceutical giant’s vaccine results, released on late-January Jan. 29, initially drew a lukewarm reaction from market participants following the 90%+ efficacy levels of other vaccines including Moderna (NASDAQ:)’s and Pfizer (NYSE:)’s mRNA vaccines. 

Analysts, however, welcomed the late-stage initial clinical results and highlighted that JNJ’s vaccine, with an 85% effective in preventing severe disease and hospitalizations/death, two primary drivers of the lockdowns and restrictions, would play a key role in reopening of economies. 

 

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button